Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 45 years of age or older
- People whose blood test shows no abnormal proteins detected using a specific laboratory method called MALDI-TOF MS
- People who have had a medical examination showing no significant health conditions, and who have been confirmed to not have any conditions relevant to this study
- People for whom enough blood, plasma, serum, and stool samples can be collected, and whose relevant health records can be provided
Who may not be able to join:
- People who have a history of bowel tumours, irritable bowel syndrome, or inflammatory bowel disease, or who were diagnosed with any of these conditions during a hospital stay
- People who have received antibiotic treatment within the past month, or who have serious ongoing health conditions including cancer
- People whose sample collection is insufficient in quantity, or whose samples show signs of problems such as broken-down blood cells, high fat content in the blood, jaundice-related changes, or other quality issues that make the samples unsuitable for testing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hongwei Zhou, Professor, Southern Medical University, China
Phone: 13928801657
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
M-protein detection; microbiome; metabonomics
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.